340 B Program

340B is vital for continuity of care, especially for underserved and undocumented patient populations.

Covered Entities (CEs) that are 340B eligible treat more low-income patients than non-340B hospitals and clinics, with savings of approximately 50% on medication costs.

CEs rely on these savings to fund critical services in the community, such as uncompensated care, substance use clinics, and vaccines.

Maximizing revenue from the 340B program is crucial for CEs to continue providing care for the underserved.

We aim to increase transparency and integrity in the 340B program by ensuring each claim is tested against HRSA audit criteria for acceptance and reporting patient clinical and financial progress.